unspecified bispecific CD19/CD22 CAR-T therapy

CD19/CD22 bispecific CAR-T · unspecified

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for unspecified bispecific CD19/CD22 CAR-T therapy, covering 2023-02-22 to 2023-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL [Phase 1, Phase 2]